The EPS projection of T2 Biosystems, Inc. (NASDAQ:TTOO) for quarter ended 2016-09-30 is $-0.53. Last week, the EPS forecast was $-0.53 against target of $-0.53, a month earlier. Two months ago, this estimate was $-0.53 versus forecast of $-0.53 three months earlier, implying a deviation of 0%.
T2 Biosystems, Inc. (NASDAQ:TTOO) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 2, and 1, correspondingly.
EPS estimate downgrade for T2 Biosystems, Inc. (NASDAQ:TTOO) in the preceding 30, 120, 60 and 90 days were 0, 1, 1, and 1, correspondingly.
T2 Biosystems, Inc. (NASDAQ:TTOO) EPS target for the quarter closed 1 was $-0.53, based on 3 recommendations. As reported on 2016-05-02 the EPS was $-0.55. The change was $0, implying a percentage deviation of 0%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
T2 Biosystems, Inc. (NASDAQ:TTOO) yearly sales prediction for the fiscal 2016 stands at $3.725 and the median estimate is at $3.725. Almost 2 analysts issued sales target.
Highest sales target is $4.45 while the lowest target is $3 showing standard deviation of 1.025%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. T2 Biosystems, Inc. (NASDAQ:TTOO) announced that the deviation in forecast was -22.797%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...